The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.
Open accessAbstract
To determine the functional importance of Ras in transformation by Abl oncogenes, we used a genetic approach to measure the effect of impaired Ras activity on the ability of Bcr-Abl or v-Abl to transform cells. Expression of the catalytic domain of the GTPase activating protein for Ras (Gap C terminus) impaired soft agar colony formation by fibroblasts expressing v-Abl or Bcr-Abl by 70-80%. To test Ras function in a model that more closely resembles clinical diseases involving Bcr-Abl, double gene retroviruses expressing Bcr-Abl paired with the Gap C terminus or dominant negative Ras were introduced into naive mouse bone marrow cells. Transformation by Bcr-Abl was completely blocked in both situations. Coexpression of normal c-H-Ras accelerated the transforming activity of Bcr-Abl. These findings show that Ras activation is essential for the leukemogenic activity of Abl oncogenes in two distinct model systems. The results genetically define a connection between the Bcr-Abl cytoplasmic tyrosine kinase and Ras and add to the accumulating evidence that deregulation of Ras is a central event in the genesis of a number of molecularly distinct forms of human myeloid leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
Leevers, S. J., Paterson, H. F., & Marshall, C. J. (1994) · Nature · doi:10.1038/369411a0 · Cited by 1,011
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., & Bowtell, D. (1993) · Nature · doi:10.1038/363083a0 · Cited by 1,009
Activation of Raf as a Result of Recruitment to the Plasma Membrane
Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M., & Hancock, J. F. (1994) · Science · doi:10.1126/science.7811320 · Cited by 976
Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.
Feig, L. A., & Cooper, G. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3235 · Cited by 798
Human Sos1: a Guanine Nucleotide Exchange Factor for Ras that Binds to GRB2
Chardin, P., Camonis, J. H., Gale, N. W., van Aelst, L., Schlessinger, J., Wigler, M. H., & Bar-Sagi, D. (1993) · Science · doi:10.1126/science.8493579 · Cited by 797
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Shannon, K. M., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P., & McCormick, F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 444
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 420
Dominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 397
Self-citationHow receptor tyrosine kinases activate ras
Schlessinger, J. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90031-h · Cited by 379
Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
Self-citationMcLaughlin, J., Chianese, E., & Witte, O. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6558 · Cited by 367
Self-citationc-Abl kinase regulates the protein binding activity of c-Crk.
Feller, S. M., Knudsen, B., & Hanafusa, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06518.x · Cited by 363
McWhirter, J. R., & Wang, J. Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05797.x · Cited by 317
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren, R., Ye, Z. S., & Baltimore, D. (1994) · Genes & Development · doi:10.1101/gad.8.7.783 · Cited by 311
Janssen, J. W., Steenvoorden, A. C., Lyons, J., Anger, B., Böhlke, J. U., Bos, J. L., Seliger, H., & Bartram, C. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9228 · Cited by 225
Dominant inhibitory mutations in the Mg(2+)-binding site of RasH prevent its activation by GTP.
Farnsworth, C. L., & Feig, L. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4822 · Cited by 211
Differential Complementation of Bcr-Abl Point Mutants with c-Myc
Afar, D. E. H., Goga, A., McLaughlin, J., Witte, O. N., & Sawyers, C. L. (1994) · Science · doi:10.1126/science.8153630 · Cited by 184
Self-citationras and GAP—Who's controlling whom?
Hall, A. (1990) · Cell · doi:10.1016/0092-8674(90)90054-i · Cited by 180
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells
Mandanas, R., Leibowitz, D., Gharehbaghi, K., Tauchi, T., Burgess, G., Miyazawa, K., Jayaram, H., & Boswell, H. (1993) · Blood · doi:10.1182/blood.v82.6.1838.1838 · Cited by 165
Suppression of c-ras transformation by GTPase-activating protein
Zhang, K., DeClue, J. E., Vass, W. C., Papageorge, A. G., McCormick, F. P., & Lowy, D. R. (1990) · Nature · doi:10.1038/346754a0 · Cited by 157
Tauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
Pendergast, A. M., Gishizky, M. L., Havlik, M. H., & Witte, O. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1728-1736.1993 · Cited by 122
Self-citationCellular interactions of CRKL, and SH2-SH3 adaptor protein.
ten Hoeve, J., Kaartinen, V., Fioretos, T., Haataja, L., Voncken, J. W., Heisterkamp, N., & Groffen, J. (1994) · PubMed · Cited by 114
Skórski, T., Kanakaraj, P., Ku, D.-H., Nieborowska-Skorska, M., Canaani, E., Zon, G., PERUSSIA, B., & Calabretta, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1855 · Cited by 98
DeClue, J. E., Zhang, K., Redford, P., Vass, W. C., & Lowy, D. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.5.2819 · Cited by 96
Inhibition of v-src-induced transformation by a GTPase-activating protein.
Nori, M., Vogel, U. S., Gibbs, W. W., & Weber, M. J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.5.2812 · Cited by 89
Druker, B. J., Okuda, K., Matulonis, U. A., Salgia, R., Roberts, T. M., & Griffin, J. D. (1992) · Blood · doi:10.1182/blood.v79.9.2215.2215 · Cited by 88
Cogswell, P., Morgan, R., Dunn, M. W., Neubauer, A., Nelson, P., Poland-Johnston, N., Sandberg, A., & Liu, E. (1989) · Blood · doi:10.1182/blood.v74.8.2629.2629 · Cited by 83
Bortner, D. M., Ulivi, M., Roussel, M. F., & Ostrowski, M. C. (1991) · Genes & Development · doi:10.1101/gad.5.10.1777 · Cited by 36
Inhibition of v-src-Induced Transformation by a GTPase-Activating Protein
Nori, M., Vogel, U. S., Gibbs, W. W., & Weber, M. J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.5.2812-2818.1991 · Cited by 20
Cited by
Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,621
Self-citationThe Biology of Chronic Myeloid Leukemia
Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,302
A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Self-citationThe biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 592
The BCR-ABL Story: Bench to Bedside and Back
Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 399
Self-citation
Metadata
- Authors
- Sawyers, C. L., McLaughlin, J., & Witte, O. N.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-01-01
- Volume
- 181
- Issue
- 1
- Pages
- 307-313
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2122883220
- Cited by
- 253
- References
- 34
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.